
Levefit 250mg Tablet
Marketer
Kasdap Healthcare Pvt Ltd
Salt Composition
Levetiracetam (250mg)
Overview Levefit 250mg Tablet
Epileptic seizures are managed with the anticonvulsant Levefit 250mg tablets. This medication, administered alone or in conjunction with other treatments, controls seizures by suppressing aberrant brain electrical activity. Consistent daily dosing, ideally at the same time, maximizes effectiveness. Dosage is individualized, determined by your physician based on your response and condition, and typically prescribed for long-term management. Continued use, as directed, is crucial; discontinuation or missed doses risk increased seizure frequency. Common, often temporary, side effects include drowsiness, headache, irritability, behavioral shifts (including aggression), and reduced appetite. While most side effects resolve spontaneously, some warrant medical attention. Rarely, suicidal ideation has been reported; report any worsening mood immediately. Prior to commencing treatment, inform your doctor of any pre-existing kidney issues, depressive symptoms, suicidal tendencies, or pregnancy/breastfeeding plans. Regular blood tests to monitor kidney function may be recommended during treatment.
Uses of Levefit 250mg Tablet
Managing Epileptic Seizures
Major Benefits of Levefit 250mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 250mg Levefit tablet whole; avoid chewing, crushing, or fracturing it. While consumption with or without food is acceptable, consistent timing is recommended for optimal results.
Common Side effects of Levefit 250mg Tablet:
- Sleepiness
- Dizziness
- Fatigue
- Headache
- Decreased appetite
- Behavioral changes
- Aggressive behavior
- Irritation
- Agitation
- Nasal congestion (stuffy nose)
- Infection
- Convulsion
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Nausea
- Tremors
- Vertigo
- Lethargy
How to use Levefit 250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The 250mg Levefit tablet should be swallowed whole; do not alter its form. While it can be taken with or without food, consistency in timing is recommended.
How Levefit 250mg Tablet works:
Levefit 250mg tablets are prescribed to control epileptic seizures. Their mechanism involves binding to synaptic vesicle protein 2A (SV2A) receptors on neurons. This action reduces aberrant neuronal firing and prevents the propagation of seizure-inducing electrical impulses within the brain.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Levefit 250mg Tablets is inadvisable.
PregnancySAFE IF PRESCRIBED
Pregnant individuals can generally use Levefit 250mg tablets safely; research indicates minimal to no fetal risk.
Breast feedingSAFE IF PRESCRIBED
Using Levefit 250mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant. Observe the infant for drowsiness and satisfactory weight increase.
DrivingUNSAFE
Taking a 250mg Levefit tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Levefit 250mg tablets. Dosage modification may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Levefit 250mg tablets in patients with liver impairment is likely safe. Current evidence indicates dose modification may be unnecessary for most such patients. Physician consultation is recommended. Nevertheless, reduced dosage might be prudent for individuals with advanced hepatic dysfunction.
What if you forget to take Levefit 250mg Tablet :
Should you forget a Levefit 250mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Levefit 250mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrrolidinone-Acetamide Derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Class | AED: A protein ligand within synaptic vesicle 2 |
